Reference7 articles.
1. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010;Liew;BMJ Open,2014
2. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial;Writing Committee for the Diabetic Retinopathy Clinical Research N;J Am Med Assoc,2015
3. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
4. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2011
5. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema;Diabetic Retinopathy Clinical Research;N Engl J Med,2015
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献